View of EFFECT OF SGLT-2 INHIBITORS ON HEPATIC STEATOSIS AND FIBROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MASLD

Return to Issue Details EFFECT OF SGLT-2 INHIBITORS ON HEPATIC STEATOSIS AND FIBROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MASLD Download Download PDF